Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 5
2013 6
2014 5
2015 8
2016 5
2017 4
2018 1
2019 8
2020 5
2021 7
2022 5
2023 4
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation.
Manzo Margiotta F, Michelucci A, Capalbo E, Ricceri F, Rosi E, Rossari S, Magnano M, Savarese I, Milanesi N, Simoni B, Romanelli M, Rubegni P, DI Cesare A, Panduri S, Pescitelli L, Trovato E, Prignano F. Manzo Margiotta F, et al. Among authors: milanesi n. Ital J Dermatol Venerol. 2024 Feb;159(1):64-65. doi: 10.23736/S2784-8671.23.07648-X. Epub 2023 Nov 23. Ital J Dermatol Venerol. 2024. PMID: 37997317 No abstract available.
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas.
Michelucci A, Margiotta FM, Cartocci A, Panduri S, Trovato E, Calpalbo E, Dragotto M, Di Cesare A, Rosi E, Rossari S, Magnano M, Pescitelli L, Buggiani G, Simoni B, Lorenzoni E, Ricceri F, Savarese I, Milanesi N, Rubegni P, Prignano F, Romanelli M. Michelucci A, et al. Among authors: milanesi n. Arch Dermatol Res. 2024 May 25;316(6):272. doi: 10.1007/s00403-024-03146-2. Arch Dermatol Res. 2024. PMID: 38796581
Severe Adult Atopic Dermatitis: Clinical Challenges.
Russo F, Flori ML, Gola M, Milanesi N. Russo F, et al. Among authors: milanesi n. Dermatitis. 2020 Jul/Aug;31(4):e48-e49. doi: 10.1097/DER.0000000000000592. Dermatitis. 2020. PMID: 32209869 No abstract available.
Photosensitivity in drug induced pellagra.
Milanesi N, Gola M, Francalanci S. Milanesi N, et al. G Ital Dermatol Venereol. 2019 Jun;154(3):366-367. doi: 10.23736/S0392-0488.17.05776-5. Epub 2017 Nov 30. G Ital Dermatol Venereol. 2019. PMID: 29192472 No abstract available.
Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab.
Russo F, Cioppa V, Lazzeri L, Milanesi N, Galluzzo M, D'Erme AM, Schettini N, Cocuroccia B, Sordi D, Panebianco A, Talamonti M, Paganini C, De Pità O, Giampetruzzi AR, Scaglione GL. Russo F, et al. Among authors: milanesi n. Dermatitis. 2024 Apr 26. doi: 10.1089/derm.2023.0357. Online ahead of print. Dermatitis. 2024. PMID: 38669092
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens.
Stingeni L, Bianchi L, Caroppo ES, Belloni Fortina A, Caroppo F, Corazza M, Borghi A, Gallo R, Trave I, Ferrucci SM, Beretta A, Guarneri F, Martina E, Napolitano M, DE Lucia M, Patruno C, Bennardo L, Romita P, Foti C, Tramontana M, Marietti R, Argenziano G, Hansel K; Skin Allergy group of SIDeMaST and Società Italiana di Dermatologia Allergologica, Professionale e Ambientale (SIDAPA). Stingeni L, et al. Ital J Dermatol Venerol. 2024 Apr;159(2):83-104. doi: 10.23736/S2784-8671.24.07733-8. Ital J Dermatol Venerol. 2024. PMID: 38650492 Free article.
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience.
Stingeni L, Bianchi L, Antonelli E, Caroppo ES, Ferrucci SM, Ortoncelli M, Fabbrocini G, Nettis E, Schena D, Napolitano M, Gola M, Bonzano L, Rossi M, Belloni Fortina A, Balato A, Peris K, Foti C, Guarneri F, Romanelli M, Patruno C, Savoia P, Fargnoli MC, Russo F, Errichetti E, Bianchelli T, Bianchi L, Pellacani G, Feliciani C, Offidani A, Corazza M, Micali G, Milanesi N, Malara G, Chiricozzi A, Tramontana M, Hansel K; DADA - Dupilumab for Atopic Dermatitis of the Adolescence Study Group. Stingeni L, et al. Among authors: milanesi n. J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1292-1299. doi: 10.1111/jdv.18141. Epub 2022 Apr 22. J Eur Acad Dermatol Venereol. 2022. PMID: 35412683 Free PMC article.
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis.
Stingeni L, Bianchi L, Antonelli E, Caroppo ES, Ferrucci SM, Gurioli C, Ortoncelli M, Fabbrocini G, Nettis E, Schena D, Napolitano M, Gola M, Bonzano L, Rossi M, Belloni Fortina A, Balato A, Peris K, Foti C, Guarneri F, Romanelli M, Patruno C, Savoia P, Esposito M, Russo F, Errichetti E, Bianchelli T, Bianchi L, Pellacani G, Feliciani C, Offidani A, Corazza M, Micali G, Milanesi N, Malara G, Chiricozzi A, Tramontana M, Hansel K; DADA - Dupilumab for Atopic Dermatitis of the Adolescence study group. Stingeni L, et al. Among authors: milanesi n. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e384-e388. doi: 10.1111/jdv.18648. Epub 2022 Oct 18. J Eur Acad Dermatol Venereol. 2023. PMID: 36225088 No abstract available.
53 results